Monoclonal antibody-based immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples

Thrombosis and Haemostasis

Volumn 79, Issue 4, 1998, Pages 808-812

  Ngo, Thu Hoa ^a   Verheyen, S ^a   Knockaert, I ^a   Declerck, P J ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL FILTRATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; THROMBOCYTE RICH PLASMA;

EID: 0031969215     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615069     Document Type: Article

References (34)

1. Kruithof EKO, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-13.
2. Declerck PJ, Man-Vague I, Felez J, Wiman B. Pathophysiology of fibrinolysis. J Int Med 1994; 236: 425-32.
3. Van Meijer M, Pannekoek H. Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update. Fibrinolysis 1995; 9: 263-76.
4. Diéval J, Nguyen G, Gross S, Delobel J, Kruithof EKO. A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type-1. Blood 1991; 77: 528-32.
5. Lee MH, Vosburgh E, Anderson K, McDonagh J. Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding. Blood 1993; 81: 2357-62.
6. Schleef RR, Higgins DL, Pillemer E, Levitt LJ. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J Clin Invest 1989; 83: 1747-52.
7. Fay WP, Shapiro AD, Shih JL, Schleef RR, Ginsburg D. Complete deficiency of plasminogen activator inhibitor type 1 due to a frame-shift mutation. N Engl J Med 1992; 327: 1729-33.
8. Hamdan AD, Quist WC, Gagne JB, Feener EP. Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta. Circulation 1996; 93: 1073-8.
9. Emeis JJ, Brower A, Barelds RJ, Koran MA, Durham SK, Kooistra T. On the fibrinolytic system in aged rats, and its reactivity to endotoxin and cytokines. Thromb Haemost 1992; 67: 679-701.
10. Gallimore MJ, Tyle HM, Shaw JTB. The measurement of fibrinolysis in the rat. Thromb Diath Haemorrh 1971; 26: 279-309.
11. Van Giezen JJJ. Modulation of fibrinolytic activity in rats and other species. PhD thesis. Universiteit Utrecht, The Netherlands, 1993.
12. Emeis JJ, Van Den Hoogen CM. Pharmacological modulation of the endotoxin-induced increase in plasminogen activator inhibitor activity in rats. Blood Coagulation and Fibrinolysis 1992; 3: 575-81.
13. Johnson MR, Bruzdzinski CJ, Winograd SS, Gelehrter TD. Regulatory sequences and protein-binding sites involved in the expression of the rat plasminogen activator inhibitor-1 gene. J Biol Chem 1992; 267: 12202-10.
14. Heaton JH, Kathju S, Gelehrter TD. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene. Expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides. Mol Endocrinol 1992; 6: 53-60.
15. Newman MJ, Lane EA, Iannotti AM, Nugent MA, Pepinsky RB, Keski-Oja J. Characterization and purification of a secreted plasminogen activator inhibitor (PAI-1) induced by transforming growth factor-1 in normal rat kidney (NRK) cells: Decreased PAI-1 expression in transformed NRK cells. Endocrinology 1990; 126: 2936-46.
16. Samama M, Nguyen G, Szwarcer E, Conrad J. Problems of t-PA specific inhibitor determination in human plasma. Thromb Haemost 1985; 54: 726.
17. Galfré F, Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 1981; 73: 3-46.
18. Ngo TH, Bijnens AP, Knockaert I, Declerck PJ. Expression, purification and characterization of recombinant rat plasminogen activator inhibitor-1. Fibrinolysis 1997; 11: 37-43.
19. Anderson PM, Potter M. Induction of plasma cell tumors in Balb/c mice with 2,6,10,4 tetramethyl-pentadecane (pristane). Nature 1969; 222: 994-5.
20. Ey PL, Prowse SJ, Jenkins CR. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulin from mouse serum using protein A-Sepharose. Immunochemistry 1978; 15: 429-36.
21. Nakane PA, Kawaoi A. Peroxidase labelled antibody. A new method for conjugation. J Histochem Cytochem 1974; 22: 1084-91.
22. Declerck PJ, Verstreken M, Collen D. An immunofunctional assay for active plasminogen activator inhibitor-1 (PAI-1). Fibrinolysis 1988; 2: 77-8.
23. Holvoet P, Cleemput H, Collen D. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies. Thromb Haemost 1985; 54: 684-7.
24. Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemost 1984; 51: 392-5.
25. Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Coilen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71: 220-5.
26. Booth NA, Simpson AJ, Croll A, Bennett B, MacGregor IR. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. BrJ Haematol 1988; 70: 327-33.
27. Kruithof EKO, Nicolosa G, Bachmann F. Plasminogen activator inhibitor 1: Development of a radioimmunoassay and observasions on its plasma concentration during venous occlusion and after platelet aggreation. Blood 1987; 70: 1645-53.
28. Declerck PJ, Verstreken M, Collen D. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb Haemost 1995; 74: 1305-9.
29. Steele P, Weily H, Davies H, Pappas G, Genton E. Platelet survival time following aortic valve replacement. Circulation 1975; 51: 358-62.
30. Steele P, Battock D, Genton E. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease. Circulation 1975; 52: 473-6.
31. Meuleman DG, Vogel GMT, Stulemeyer SM, Moelker HCT. Analysis of platelet survival curves in an arterial thrombosis model in rat. Thromb Res 1980; 20: 31-43.
32. Meuleman DG, Vogel GMT, van Delft AML. Effects of intra-arterial cannulation on blood platelet consumption in rats. Thromb Res 1980; 20: 45-55.
33. Declerck PJ, De Mol M, Alessi MC, Baudner S, Pâques EP, Preissner KT, Müller-Berghaus KT, Collen D. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. J Biol Chem 1988; 263: 5454-61.
34. Wiman B, Lindahl T, Almquist Å. Evidence for a discrete binding protein of plasminogen activator inhibitor in plasma. Thromb Haemost 1988; 59: 392-5.